| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 |
| filingDate |
1999-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2d2ea18a7879f6bcf68b86963a3f622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8b5ac19c4c73486c823925b1a5d95da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20cfa1b0a034f42c714313750614699a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2aea65d8f0d9f1d3e336f919ad391a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01607f390e59d7ad23eec4462c9e1e90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99e95c5b9bd307be70654477efefbcf7 |
| publicationDate |
2008-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2290613-T3 |
| titleOfInvention |
COMPOSITIONS THAT INCLUDE VIRUSES AND METHODS TO CONCENTRATE VIRUS PREPARATIONS. |
| abstract |
A method of purifying a virus preparation comprising: (a) subjecting the virus preparation to anion exchange chromatography, wherein the virus is eluted as a product of a virus preparation from an anion exchange chromatographic medium; (b) adding a polyhydroxylated hydrocarbon to the virus product preparation of step (a) so that the concentration of polyhydroxylated hydrocarbon in the preparation reaches a final concentration of about 25% or more; (c) increasing the virus concentration in the virus preparation product of step (b) by applying pressure to the preparation such that diluent is separated from the virus preparation through a filter while the virus is retained ; and (d) subjecting the product of the concentrated virus preparation of step (c) to one or more stages of additional treatments. |
| priorityDate |
1998-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |